The upregulation of PD-1 expression was associated with tumour antigen-specific CD8+ T cell dysfunction in NSCLC, and PD-1+ CD8+ T cells could result in immunosuppression in cancer [18,21]. The gene discussed is CD8A; the disease is cancer.